Provided by Tiger Trade Technology Pte. Ltd.

Tscan Therapeutics, Inc.

0.9286
-0.0233-2.45%
Pre-market: 0.94720.0186+2.00%08:30 EST
Volume:476.47K
Turnover:455.46K
Market Cap:52.70M
PE:-0.37
High:0.9879
Open:0.9700
Low:0.9200
Close:0.9519
52wk High:3.43
52wk Low:0.9100
Shares:56.75M
Float Shares:44.03M
Volume Ratio:1.18
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5128
EPS(LYR):-2.2530
ROE:-76.44%
ROA:-30.45%
PB:0.37
PE(LYR):-0.41

Loading ...

TScan Therapeutics Reports Positive Phase 1 Results for TSC-101 in Heme Malignancies

Reuters
·
Dec 07

TScan Therapeutics Announces Positive Updated Data From the Alloha™ Phase 1 Heme Trial at the 67TH American Society of Hematology Annual Meeting and Exposition

THOMSON REUTERS
·
Dec 07

TScan Therapeutics Announces Updated ALLOHA Phase 1 Trial Data and Plans for Pivotal Study in 2026

Reuters
·
Dec 04

TScan Therapeutics Approves Key Employee Retention Program

TIPRANKS
·
Nov 27

TScan Therapeutics Expects $2.3 Million One-Time Charge For Severance During 3 Months Ended Dec 31

Reuters
·
Nov 20

TScan Therapeutics (TCRX) was downgraded to a Hold Rating at Morgan Stanley

TIPRANKS
·
Nov 14

H.C. Wainwright Keeps Their Buy Rating on TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 13

LifeSci Capital Reaffirms Their Buy Rating on TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 13

TScan Therapeutics Q3 revenue jumps

Reuters
·
Nov 12

BRIEF-TScan Therapeutics Q3 Net Income USD -35.71 Million

Reuters
·
Nov 12

TScan Therapeutics Q3 Income From Operations USD -37.052 Million

THOMSON REUTERS
·
Nov 12

LifeSci Capital Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 12

TScan Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
Nov 07

LifeSci Capital Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 05

TScan Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
Nov 04

Barclays Reaffirms Their Buy Rating on TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 04

TScan Therapeutics to reduce workforce by 30%

TIPRANKS
·
Nov 03

BRIEF-TScan Therapeutics Announces 30% Workforce Reduction, Cash Runway Extension

Reuters
·
Nov 03

BRIEF-TScan Therapeutics Expects $2.3 Million One-Time Charge For Severance During 3 Months Ended Dec 31

Reuters
·
Nov 03

TScan Therapeutics Inc - Expects $2.3 Mln One-Time Charge for Severance During 3 Months Ended Dec 31 - SEC Filing

THOMSON REUTERS
·
Nov 03